Rights and permissions
About this article
Cite this article
Consider the costs of NSAID/antiulcer co-prescribing. Pharmacoecon. Outcomes News 50, 7 (1996). https://doi.org/10.1007/BF03269822
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269822